$40 Million - Follow-OnSole Bookrunner
Marinus Pharmaceuticals, Inc.
$45 Million - Follow-OnJoint Bookrunner
$30 Million - Follow-OnJoint Bookrunner
Healthcare / 2019 Outlook: Macro Visibility Poor, It’s a Stockpicker’s Year in Healthcare
ADMS / Using Drug Delivery Tech to Make Better Drugs; Initiating ADMS with OP
CLL Survey Suggests Significant Opp for Next-Gen BTKs to Improve on Imbruvica